BlackRock’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.64M | Sell |
533,467
-1,142,801
| -68% | -$3.51M | ﹤0.01% | 4049 |
|
2025
Q1 | $3.24M | Buy |
1,676,268
+3,775
| +0.2% | +$7.29K | ﹤0.01% | 3769 |
|
2024
Q4 | $6.26M | Buy |
1,672,493
+152,232
| +10% | +$569K | ﹤0.01% | 3590 |
|
2024
Q3 | $7.43M | Buy |
1,520,261
+66,594
| +5% | +$326K | ﹤0.01% | 3508 |
|
2024
Q2 | $10.9M | Buy |
1,453,667
+703,701
| +94% | +$5.28M | ﹤0.01% | 3294 |
|
2024
Q1 | $18.6M | Buy |
+749,966
| New | +$18.6M | ﹤0.01% | 2977 |
|